.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
orchid pharma faces liquidation as lenders reject resolution plan
.
https://drbryanpwalsh.com/Azatyan-grandpa-of-Ambrogi-from-Faro?Rizalbrot=226
.